Barriers to Timely Follow-up for Heart Failure Hospitalization
Researchers examine patient barriers when receiving follow-up for heart failure hospitalization.
Diagnosis & Disease Information
Risk Model May Predict Stroke in Patients With HFpEF Without AF
Researchers sought to determine the rate of stroke in patients with heart failure with preserved ejection fraction without atrial fibrillation.
Latest 2023 FDA Approvals
Recent FDA approvals include treatments for postpartum depression, RSV in infants, pediatric constipation, metastatic colorectal cancer, and iron deficiency.
Increasing Daily Step Counts Tied to Improved Heart Failure Outcomes
Self-reported health status better for patients increasing step counts over 12 weeks.
Cardiac Amyloidosis: Tips For Early Recognition and Treatment
Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment.
Obesity Linked to Lower Short-Term Mortality in Patients With HF With Well-Nourished Status
Researchers studied the effect of nutritional status on the association between obesity and mortality among patients with acute heart failure.
FDA Approves Inpefa for the Treatment of Heart Failure
Inpefa is expected to be available by the end of June 2023.
Hemodynamic Monitoring Beneficial for Chronic Heart Failure
Hemodynamic monitoring improved Kansas City Cardiomyopathy Questionnaire with CardioMEMS-HF system vs standard care
Farxiga Approval Expands Use to More Patients With Heart Failure
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
Risk for CVD, Heart Failure Increased Among Black Patients With Gout
Researchers studied the effect of gout on cardiovascular events, including CVD and heart failure, in a Black urban population.
- Loading...
Loading...
Next post in Cardiovascular Disease Information Center
Loading... 
Loading...